SCOTTSDALE, Ariz., Feb. 15, 2011 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company, announces the launch of AperFix® II, its second generation soft tissue repair device for multi-ligament repairs of the knee. The announcement was made today at the 2011 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in San Diego, CA.
Key to AperFix II is the introduction of its new Cannulated Tibial System, which provides surgeons with increased ease-of-insertion and standardized positioning of the implant. For anterior cruciate ligament (ACL) repair, the system allows for rotation of the two tendons representing the anteromedial (AM) and posterolateral (PL) bundles to more accurately match the positioning of the native ACL bundles. Additionally, new enhancements to the femoral device allow for easier graft insertion and placement within the tunnel.
“The AperFix II System offers a simple and efficient technique to obtain consistent circumferential graft compression, restoring native knee kinematics,” said Kenneth Montgomery MD, orthopedic surgeon, Tri-County Orthopaedic & Sports Medicine, Morristown, NJ. “I believe this procedural enhancement will ensure the integrity and strength of the reconstructed ligament, providing patients with a more stable knee.”
The addition of the Cannulated Tibial System, along with enhancements to the femoral device, serve to strengthen Cayenne Medical’s innovative AperFix ligament reconstruction technology, which utilizes a single tunnel, all-inside approach for attaching the soft tissue graft at the aperture of the femoral and tibial tunnels. This technique creates a shorter, stiffer and more anatomic ligament repair.
“As the industry continues to lean in favor of soft tissue ligament reconstruction, we have seen much success with our flagship product AperFix and an increasing interest in its anatomic repair through aperture graft fixation,” said James W. Hart, Executive Chairman, Cayenne Medical. “The strategic enhancements we’ve made to the tibial portion of the procedure with AperFix II are in line with this trend and affirm our commitment to evolving our technology platform for the benefit of surgeons and their patients.”
The AperFix II Cannulated Tibial System includes the tibial implant made from PEEK polymer, a tendon expander, a guide wire, a cannulated screw and a driver pre-loaded with tibial sheaths and a sheath holder.
AperFix II is available for demonstration at the Cayenne Medical AAOS Booth (#406) and is available to surgeons upon request ahead of the upcoming commercial rollout.
Cayenne Medical also markets CrossFix® Meniscal Repair System for the treatment of repairable traumatic meniscal tears and the iFix® System for bone-tendon-bone ACL reconstruction. For more information about AperFix® II or Cayenne Medical, please visit www.cayennemedical.com.
About Cayenne Medical, Inc.:
Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional ACL, PCL and meniscal repair procedures, by applying advanced technology through minimally invasive techniques. For more information, visit www.cayennemedical.com.
Contacts: | Tim Nash | Kimberly Muscara | |
(480) 502-3661 | (646) 536-7011/(973) 768-0449 | ||
tnash@cayennemedical.com | kmuscara@theruthgroup.com | ||
SOURCE Cayenne Medical, Inc.
